High-level Sofra overview presented to local industry audience. 

Technical oligonucleotide presentation to leading researchers and industry experts.

Technical Sofra presentation to international audience.

Corporate and Sofra overview given to international industry audience. 

Technical presentation on ultra-short oligonucleotides for modulation of inflammation.

Technical presentation on ultra-short oligonucleotides for modulation of inflammation.

Corporate presentation and meetings with business-focused audience. 

Sofra-focused presentation to international industry audience. 

Technical TLR7-focused presentation to specialist international audience.

Corporate overview presentation to local investor audience.

Nature Communications paper showing inhibition of TBK1/IKKε signalling through destabilisation of TBK1/IKKε protein complexes.

Presentation showing Sofra technology’s effectiveness against inflammatory skin disease.

Publication in Cancer Research examining therapeutic potential in a patient-derived PDAC tumor explant model.

Corporate overview presentation to local investor audience.

Nature paper establishing the importance of TLR7 and guanosine-containing self-ligands for human lupus pathogenesis.

Nucleic Acids Research analysis of the immunomodulatory effect of 2′OMe antisense oligonucleotides on nucleic acid sensing.

Nucleic Acids Research paper identifying the core motifs preventing immunosuppressive activities on TLR7.